Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema
Identifieur interne : 002D94 ( Pmc/Curation ); précédent : 002D93; suivant : 002D95Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema
Auteurs : Ye Im Bakar [Turquie] ; Alper Tu Ral [Turquie] ; Özlem Özdemir [Turquie] ; Elif Duygu [Turquie] ; Ümmügül Üyetürk [Turquie]Source :
- European Journal of Breast Health [ 2587-0831 ] ; 2017.
Abstract
Breast cancer related lymphedema (BCRL) is a drastic situation that affects patients who have undergone breast cancer surgery. The impact of this condition on individuals’ quality of life should be investigated in more detail to obtain better treatment results.
In total, 65 patients with BCRL participated in this study. Nottingham Health Profile (NHP) was used to evaluate the validity of associated domains in Lymphedema Quality of Life Tool (LYMQoL). Both the LYMQoL and NHP were filled out by BCRL patients. To evaluate its test-retest reliability, the LYMQoL was subsequently performed seven days following its initial application. Measurement properties such as internal consistency, test-retest reliability, criterion validity and factor structure were tested. The internal consistency was assessed via Cronbach’s alpha; test-retest reliability was assessed by the intra-class correlation coefficient (ICC).
Cronbach’s alpha values ranged from 0.74 to 0.91 for the LYMQoL total and domain scores. Test-retest reliability was excellent (ICC=0.92–0.99). When the relation between LYMQoL and NHP was investigated, ‘good’ to ‘very good’ correlations were obtained (r=0.539–0.643, p<0.05) for all domains of LYMQoL. Exploratory factor analyses demonstrated a four-factor structure.
Turkish version of LYMQoL is a valid and reliable measurement tool to evaluate the quality of life in patients with BCRL.
Url:
DOI: 10.5152/ejbh.2017.3522
PubMed: 28894851
PubMed Central: 5544147
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002D95
Links to Exploration step
PMC:5544147Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema</title>
<author><name sortKey="Bakar, Ye Im" sort="Bakar, Ye Im" uniqKey="Bakar Y" first="Ye Im" last="Bakar">Ye Im Bakar</name>
<affiliation wicri:level="1"><nlm:aff id="af1-jbh-13-3-123">School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tu Ral, Alper" sort="Tu Ral, Alper" uniqKey="Tu Ral A" first="Alper" last="Tu Ral">Alper Tu Ral</name>
<affiliation wicri:level="1"><nlm:aff id="af1-jbh-13-3-123">School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ozdemir, Ozlem" sort="Ozdemir, Ozlem" uniqKey="Ozdemir O" first="Özlem" last="Özdemir">Özlem Özdemir</name>
<affiliation wicri:level="1"><nlm:aff id="af1-jbh-13-3-123">School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Duygu, Elif" sort="Duygu, Elif" uniqKey="Duygu E" first="Elif" last="Duygu">Elif Duygu</name>
<affiliation wicri:level="1"><nlm:aff id="af1-jbh-13-3-123">School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Uyeturk, Ummugul" sort="Uyeturk, Ummugul" uniqKey="Uyeturk U" first="Ümmügül" last="Üyetürk">Ümmügül Üyetürk</name>
<affiliation wicri:level="1"><nlm:aff id="af2-jbh-13-3-123">Department of Medical Oncology, Abant Izzet Baysal University School of Medicine, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Medical Oncology, Abant Izzet Baysal University School of Medicine, Bolu</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">28894851</idno>
<idno type="pmc">5544147</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544147</idno>
<idno type="RBID">PMC:5544147</idno>
<idno type="doi">10.5152/ejbh.2017.3522</idno>
<date when="2017">2017</date>
<idno type="wicri:Area/Pmc/Corpus">002D95</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002D95</idno>
<idno type="wicri:Area/Pmc/Curation">002D94</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002D94</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema</title>
<author><name sortKey="Bakar, Ye Im" sort="Bakar, Ye Im" uniqKey="Bakar Y" first="Ye Im" last="Bakar">Ye Im Bakar</name>
<affiliation wicri:level="1"><nlm:aff id="af1-jbh-13-3-123">School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tu Ral, Alper" sort="Tu Ral, Alper" uniqKey="Tu Ral A" first="Alper" last="Tu Ral">Alper Tu Ral</name>
<affiliation wicri:level="1"><nlm:aff id="af1-jbh-13-3-123">School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ozdemir, Ozlem" sort="Ozdemir, Ozlem" uniqKey="Ozdemir O" first="Özlem" last="Özdemir">Özlem Özdemir</name>
<affiliation wicri:level="1"><nlm:aff id="af1-jbh-13-3-123">School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Duygu, Elif" sort="Duygu, Elif" uniqKey="Duygu E" first="Elif" last="Duygu">Elif Duygu</name>
<affiliation wicri:level="1"><nlm:aff id="af1-jbh-13-3-123">School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Uyeturk, Ummugul" sort="Uyeturk, Ummugul" uniqKey="Uyeturk U" first="Ümmügül" last="Üyetürk">Ümmügül Üyetürk</name>
<affiliation wicri:level="1"><nlm:aff id="af2-jbh-13-3-123">Department of Medical Oncology, Abant Izzet Baysal University School of Medicine, Bolu, Turkey</nlm:aff>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Medical Oncology, Abant Izzet Baysal University School of Medicine, Bolu</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">European Journal of Breast Health</title>
<idno type="eISSN">2587-0831</idno>
<imprint><date when="2017">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec><title>Objective</title>
<p>Breast cancer related lymphedema (BCRL) is a drastic situation that affects patients who have undergone breast cancer surgery. The impact of this condition on individuals’ quality of life should be investigated in more detail to obtain better treatment results.</p>
</sec>
<sec><title>Materials and Methods</title>
<p>In total, 65 patients with BCRL participated in this study. Nottingham Health Profile (NHP) was used to evaluate the validity of associated domains in Lymphedema Quality of Life Tool (LYMQoL). Both the LYMQoL and NHP were filled out by BCRL patients. To evaluate its test-retest reliability, the LYMQoL was subsequently performed seven days following its initial application. Measurement properties such as internal consistency, test-retest reliability, criterion validity and factor structure were tested. The internal consistency was assessed via Cronbach’s alpha; test-retest reliability was assessed by the intra-class correlation coefficient (ICC).</p>
</sec>
<sec><title>Results</title>
<p>Cronbach’s alpha values ranged from 0.74 to 0.91 for the LYMQoL total and domain scores. Test-retest reliability was excellent (ICC=0.92–0.99). When the relation between LYMQoL and NHP was investigated, ‘good’ to ‘very good’ correlations were obtained (r=0.539–0.643, p<0.05) for all domains of LYMQoL. Exploratory factor analyses demonstrated a four-factor structure.</p>
</sec>
<sec><title>Conclusion</title>
<p>Turkish version of LYMQoL is a valid and reliable measurement tool to evaluate the quality of life in patients with BCRL.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Breast Health</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur J Breast Health</journal-id>
<journal-title-group><journal-title>European Journal of Breast Health</journal-title>
</journal-title-group>
<issn pub-type="epub">2587-0831</issn>
<publisher><publisher-name>Turkish Federation of Breast Diseases Associations</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">28894851</article-id>
<article-id pub-id-type="pmc">5544147</article-id>
<article-id pub-id-type="doi">10.5152/ejbh.2017.3522</article-id>
<article-id pub-id-type="publisher-id">jbh-13-3-123</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Bakar</surname>
<given-names>Yeşim</given-names>
</name>
<xref ref-type="aff" rid="af1-jbh-13-3-123">1</xref>
<xref ref-type="corresp" rid="c1-jbh-13-3-123"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Tuğral</surname>
<given-names>Alper</given-names>
</name>
<xref ref-type="aff" rid="af1-jbh-13-3-123">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Özdemir</surname>
<given-names>Özlem</given-names>
</name>
<xref ref-type="aff" rid="af1-jbh-13-3-123">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Duygu</surname>
<given-names>Elif</given-names>
</name>
<xref ref-type="aff" rid="af1-jbh-13-3-123">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Üyetürk</surname>
<given-names>Ümmügül</given-names>
</name>
<xref ref-type="aff" rid="af2-jbh-13-3-123">2</xref>
</contrib>
</contrib-group>
<aff id="af1-jbh-13-3-123"><label>1</label>
School of Physical Therapy and Rehabilitation, Abant Izzet Baysal University, Bolu, Turkey</aff>
<aff id="af2-jbh-13-3-123"><label>2</label>
Department of Medical Oncology, Abant Izzet Baysal University School of Medicine, Bolu, Turkey</aff>
<author-notes><corresp id="c1-jbh-13-3-123">Address for Correspondence : Yeşim Bakar, e-mail: <email>ptyesim@yahoo.de</email>
</corresp>
</author-notes>
<pub-date pub-type="collection"><month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub"><day>01</day>
<month>7</month>
<year>2017</year>
</pub-date>
<volume>13</volume>
<issue>3</issue>
<fpage>123</fpage>
<lpage>128</lpage>
<history><date date-type="received"><day>25</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted"><day>01</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions><copyright-statement>Copyright © 2017 Turkish Federation of Breast Diseases Associations</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract><sec><title>Objective</title>
<p>Breast cancer related lymphedema (BCRL) is a drastic situation that affects patients who have undergone breast cancer surgery. The impact of this condition on individuals’ quality of life should be investigated in more detail to obtain better treatment results.</p>
</sec>
<sec><title>Materials and Methods</title>
<p>In total, 65 patients with BCRL participated in this study. Nottingham Health Profile (NHP) was used to evaluate the validity of associated domains in Lymphedema Quality of Life Tool (LYMQoL). Both the LYMQoL and NHP were filled out by BCRL patients. To evaluate its test-retest reliability, the LYMQoL was subsequently performed seven days following its initial application. Measurement properties such as internal consistency, test-retest reliability, criterion validity and factor structure were tested. The internal consistency was assessed via Cronbach’s alpha; test-retest reliability was assessed by the intra-class correlation coefficient (ICC).</p>
</sec>
<sec><title>Results</title>
<p>Cronbach’s alpha values ranged from 0.74 to 0.91 for the LYMQoL total and domain scores. Test-retest reliability was excellent (ICC=0.92–0.99). When the relation between LYMQoL and NHP was investigated, ‘good’ to ‘very good’ correlations were obtained (r=0.539–0.643, p<0.05) for all domains of LYMQoL. Exploratory factor analyses demonstrated a four-factor structure.</p>
</sec>
<sec><title>Conclusion</title>
<p>Turkish version of LYMQoL is a valid and reliable measurement tool to evaluate the quality of life in patients with BCRL.</p>
</sec>
</abstract>
<kwd-group><kwd>Validity</kwd>
<kwd>Reliability</kwd>
<kwd>Lymphedema Quality of Life Tool</kwd>
<kwd>Turkish version</kwd>
<kwd>Breast Cancer Related Lymphedema</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D94 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 002D94 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:5544147 |texte= Translation and Validation of the Turkish Version of Lymphedema Quality of Life Tool (LYMQOL) in Patients with Breast Cancer Related Lymphedema }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:28894851" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |